KVP Capital Advisors, LP
CIK 1858198 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $136.2M
- Posisi
- 35
- Per tanggal
- 30 Juni 2026
#7.684 dari 9.443 berdasarkan nilai 13F · top 81.4%
Nilai portofolio QoQ: +1.7% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 57,41%
- Bobot 25 kepemilikan teratas
- 89,22%
- Posisi di atas 1%
- 32
- Jumlah posisi efektif
- 22,2
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 13,86% Perkiraan pembelian $18.714.663 · penjualan $37.982.560
- Posisi baru
- 6
- Meningkat
- 2
- Menurun
- 2
- Tertutup
- 3
Di halaman ini
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Rincian sektor
Healthcare
100,0%
Portofolio lengkap 35 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $14.362.491 | 10,54% | 42.900 | $540.540 | |||
| WHWK Whitehawk Therapeutics, Inc. - Common Stock | $9.920.266 | 7,28% | 2.165.997 | $2.447.576 | |||
| ERAS Erasca, Inc. - Common Stock | $8.335.600 | 6,12% | 455.000 | $2.834.400 | Naik ×1 | ||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $7.721.100 | 5,67% | 414.000 | $2.782.080 | |||
| STRO Sutro Biopharma, Inc. - Common Stock | $7.522.290 | 5,52% | 226.575 | $1.878.307 | |||
| TNGX Tango Therapeutics, Inc. - Common Stock | $7.198.053 | 5,28% | 230.264 | $2.380.930 | |||
| MBX MBX Biosciences, Inc. - Common Stock | $6.708.125 | 4,92% | 121.524 | $3.080.634 | |||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $6.496.740 | 4,77% | 53.000 | $910.540 | |||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $5.403.790 | 3,97% | 133.000 | $1.214.290 | |||
| TNDM Tandem Diabetes Care, Inc. - Common Stock | $4.542.090 | 3,33% | 301.000 | Naik ×1 | |||
| IRON Disc Medicine, Inc. - Common Stock | $4.260.405 | 3,13% | 58.250 | $535.900 | |||
| SVRA Savara, Inc. - Common Stock | $3.728.525 | 2,74% | 605.280 | $423.696 | |||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $3.543.480 | 2,60% | 102.000 | Naik ×1 | |||
| INSM Insmed Incorporated - Common Stock | $3.038.350 | 2,23% | 28.497 | $-1.621.479 | |||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $3.019.178 | 2,22% | 462.355 | $1.659.854 | |||
| IDYA IDEAYA Biosciences, Inc. - Common Stock | $2.970.419 | 2,18% | 79.700 | $314.815 | |||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $2.946.000 | 2,16% | 300.000 | $405.000 | |||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $2.937.240 | 2,16% | 12.000 | $-3.181.284 | Turun ×1 | ||
| DSGN Design Therapeutics, Inc. - Common Stock | $2.676.950 | 1,96% | 185.000 | Naik ×1 | |||
| UTHR United Therapeutics Corporation - Common Stock | $2.573.693 | 1,89% | 4.750 | $-242.962 | |||
| SRRK Scholar Rock Holding Corporation - Common Stock | $2.475.000 | 1,82% | 45.000 | $262.800 | |||
| IMMX Immix Biopharma, Inc. - Common Stock | $2.375.661 | 1,74% | 230.423 | $276.507 | |||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $2.296.250 | 1,69% | 125.000 | $-148.750 | |||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $2.270.853 | 1,67% | 84.168 | Naik ×1 | |||
| DRUG Bright Minds Biosciences Inc. - common stock | $2.233.273 | 1,64% | 31.813 | $-88.122 | |||
| TVTX Travere Therapeutics, Inc. - Common Stock | $2.215.590 | 1,63% | 39.000 | $-488.020 | Turun ×1 | ||
| ZURA Zura Bio Limited - Class A Ordinary shares | $2.201.455 | 1,62% | 373.128 | $-18.657 | |||
| ARTV Artiva Biotherapeutics, Inc. - Common Stock | $1.940.000 | 1,42% | 200.000 | Naik ×1 | |||
| NKTR Nektar Therapeutics - Common Stock | $1.877.889 | 1,38% | 26.900 | $-57.566 | |||
| CMPX Compass Therapeutics, Inc. - Common Stock | $1.688.490 | 1,24% | 771.000 | $-956.510 | Naik ×1 | ||
| CABA Cabaletta Bio, Inc. - Common Stock | $1.571.890 | 1,15% | 505.431 | $212.281 | |||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $1.403.157 | 1,03% | 32.700 | $87.636 | |||
| EOLS Evolus, Inc. - Common Stock | $1.041.000 | 0,76% | 150.000 | Naik ×1 | |||
| CELC Celcuity Inc. - Common Stock | $418.480 | 0,31% | 4.000 | $-38.080 | |||
| VYNE VYNE Therapeutics Inc. - Common Stock | $325.709 | 0,24% | 500.551 | $26.630 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| AXSM | Dipangkas | -24K | -$3.2M |
| MBX | Hanya pergerakan harga | +0 | +$3.1M |
| ERAS | Beli lebih banyak | +115K | +$2.8M |
| TRVI | Hanya pergerakan harga | +0 | +$2.8M |
| WHWK | Hanya pergerakan harga | +0 | +$2.4M |
| TNGX | Hanya pergerakan harga | +0 | +$2.4M |
| STRO | Hanya pergerakan harga | +0 | +$1.9M |
| ACHV | Hanya pergerakan harga | +0 | +$1.7M |
| INSM | Hanya pergerakan harga | +0 | -$1.6M |
| EWTX | Hanya pergerakan harga | +0 | +$1.2M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| TERN | 30 Juni 2026 | 440.000 | $23.196.800 | Tidak lagi dilacak |
| RVMD | 30 Juni 2026 | 40.200 | $3.909.450 | 13,4% |
| JAZZ | 31 Maret 2026 | 17.500 | $2.975.000 | 32,4% |
| SLNO | 30 Juni 2026 | 59.700 | $1.998.756 | Tidak lagi dilacak |
| FULC | 31 Maret 2026 | 50.000 | $565.500 | -49,4% |